Clinicopathologic characteristics of patients with stage III/IV (M(0)) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples